TRANXENE SD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tranxene Sd, and what generic alternatives are available?
Tranxene Sd is a drug marketed by Ajenat Pharms and is included in one NDA.
The generic ingredient in TRANXENE SD is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tranxene Sd
A generic version of TRANXENE SD was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRANXENE SD?
- What are the global sales for TRANXENE SD?
- What is Average Wholesale Price for TRANXENE SD?
Summary for TRANXENE SD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 3 |
DailyMed Link: | TRANXENE SD at DailyMed |
Recent Clinical Trials for TRANXENE SD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assistance Publique - Hôpitaux de Paris | Phase 3 |
Polish Lymphoma Research Group | Phase 4 |
Ranbaxy Laboratories Limited | N/A |
US Patents and Regulatory Information for TRANXENE SD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajenat Pharms | TRANXENE SD | clorazepate dipotassium | TABLET;ORAL | 017105-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajenat Pharms | TRANXENE SD | clorazepate dipotassium | TABLET;ORAL | 017105-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRANXENE SD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ajenat Pharms | TRANXENE SD | clorazepate dipotassium | TABLET;ORAL | 017105-005 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ajenat Pharms | TRANXENE SD | clorazepate dipotassium | TABLET;ORAL | 017105-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRANXENE SD
See the table below for patents covering TRANXENE SD around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 1117063 | ⤷ Sign Up | |
Yugoslavia | 45468 | ⤷ Sign Up | |
Norway | 120115 | ⤷ Sign Up | |
Denmark | 135591 | ⤷ Sign Up | |
Malaysia | 7100179 | ORTHO-AMINOARYLKETIMINES | ⤷ Sign Up |
Yugoslavia | 100565 | ⤷ Sign Up | |
Germany | 1795445 | VERFAHREN ZUR HERSTELLUNG VON 2-OXO-2,3-DIHYDRO-1H-1,4-BENZODIAZEPINDERIVATEN | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |